Literature DB >> 27987641

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

Thomas Wilkinson1, Mark J Sculpher2, Karl Claxton3, Paul Revill2, Andrew Briggs4, John A Cairns5, Yot Teerawattananon6, Elias Asfaw7, Ruth Lopert8, Anthony J Culyer9, Damian G Walker10.   

Abstract

BACKGROUND: Policymakers in high-, low-, and middle-income countries alike face challenging choices about resource allocation in health. Economic evaluation can be useful in providing decision makers with the best evidence of the anticipated benefits of new investments, as well as their expected opportunity costs-the benefits forgone of the options not chosen. To guide the decisions of health systems effectively, it is important that the methods of economic evaluation are founded on clear principles, are applied systematically, and are appropriate to the decision problems they seek to inform.
METHODS: The Bill and Melinda Gates Foundation, a major funder of economic evaluations of health technologies in low- and middle-income countries (LMICs), commissioned a "reference case" through the International Decision Support Initiative (iDSI) to guide future evaluations, and improve both the consistency and usefulness to decision makers.
RESULTS: The iDSI Reference Case draws on previous insights from the World Health Organization, the US Panel on Cost-Effectiveness in Health Care, and the UK National Institute for Health and Care Excellence. Comprising 11 key principles, each accompanied by methodological specifications and reporting standards, the iDSI Reference Case also serves as a means of identifying priorities for methods research, and can be used as a framework for capacity building and technical assistance in LMICs.
CONCLUSIONS: The iDSI Reference Case is an aid to thought, not a substitute for it, and should not be followed slavishly without regard to context, culture, or history. This article presents the iDSI Reference Case and discusses the rationale, approach, components, and application in LMICs.
Copyright © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27987641     DOI: 10.1016/j.jval.2016.04.015

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  72 in total

Review 1.  The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.

Authors:  Eduardo Edelman Saul; Raquel B Guerra; Michelle Edelman Saul; Laercio Lopes da Silva; Gabriel F P Aleixo; Raquel M K Matuda; Gilberto Lopes
Journal:  Nat Cancer       Date:  2020-11-30

2.  Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.

Authors:  James Lomas; Karl Claxton; Jessica Ochalek
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

3.  Economic evaluation of interventions to address undernutrition: a systematic review.

Authors:  Francesco Ramponi; Wiktoria Tafesse; Susan Griffin
Journal:  Health Policy Plan       Date:  2021-05-17       Impact factor: 3.344

4.  Economic Aspects of Delivering Primary Care Services: An Evidence Synthesis to Inform Policy and Research Priorities.

Authors:  Lorcan Clarke; Michael Anderson; Rob Anderson; Morten Bonde Klausen; Rebecca Forman; Jenna Kerns; Adrian Rabe; Søren Rud Kristensen; Pavlos Theodorakis; Jose Valderas; Hans Kluge; Elias Mossialos
Journal:  Milbank Q       Date:  2021-09-02       Impact factor: 4.911

5.  How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.

Authors:  Amanda Glassman; Oscar Cañón; Rachel Silverman
Journal:  Value Health       Date:  2016-12       Impact factor: 5.725

6.  Editorial.

Authors:  Andrew Briggs; Rachel Nugent
Journal:  Health Econ       Date:  2016-02       Impact factor: 3.046

7.  We need a NICE for global development spending.

Authors:  Kalipso Chalkidou; Anthony J Culyer; Amanda Glassman; Ryan Li
Journal:  F1000Res       Date:  2017-07-25

8.  How Should Global Fund Use Value-for-Money Information to Sustain its Investments in Graduating Countries?

Authors:  Kitti Kanpirom; Alia Cynthia G Luz; Kalipso Chalkidou; Yot Teerawattananon
Journal:  Int J Health Policy Manag       Date:  2017-09-01

9.  An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.

Authors:  Nyashadzaishe Mafirakureva; Jack Stone; Hannah Fraser; Yvonne Nzomukunda; Aron Maina; Angela W Thiong'o; Kibango Walter Kizito; Esther W K Mucara; C Inés González Diaz; Helgar Musyoki; Bernard Mundia; Peter Cherutich; Mercy Nyakowa; John Lizcano; Nok Chhun; Ann Kurth; Matthew J Akiyama; Wanjiru Waruiru; Parinita Bhattacharjee; Charles Cleland; Dmytro Donchuk; Niklas Luhmann; Anne Loarec; David Maman; Josephine Walker; Peter Vickerman
Journal:  Addiction       Date:  2021-07-28       Impact factor: 6.526

10.  Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe.

Authors:  Collin Mangenah; Webster Mavhu; Diego Cerecero Garcia; Chiedza Gavi; Polite Mleya; Progress Chiwawa; Sandra Chidawanyika; Getrude Ncube; Sinokuthemba Xaba; Owen Mugurungi; Noah Taruberekera; Ngonidzashe Madidi; Katherine L Fielding; Cheryl Johnson; Karin Hatzold; Fern Terris-Prestholt; Frances M Cowan; Sergio Bautista-Arredondo
Journal:  BMJ Glob Health       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.